Condition: Haemorrhagic Shock · Trauma Coagulopathy · Sponsor: Medical University of Graz
The investigators will evaluate the implementation of a treatment bundle (Fibrinogen, Plasma and Tranexamic Acid)
This description comes directly from the study's public registry record.
Gabriel Honnef, MD, PhD · +436509160890 · gabriel.honnef@medunigraz.at
Always discuss trial participation with your own doctor first.
| Medical University of Graz | Graz, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06891131